395 related articles for article (PubMed ID: 16199631)
1. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
[TBL] [Abstract][Full Text] [Related]
2. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
Wang ZP; Li H; Hao LZ; Zhao ZT
Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic ultrasound: early detection of fetal neural tube defects.
Robinson HP; Hood VD; Adam AH; Gibson AA; Ferguson-Smith MA
Obstet Gynecol; 1980 Dec; 56(6):705-10. PubMed ID: 6160439
[TBL] [Abstract][Full Text] [Related]
5. Early pregnancy screening for neural tube defects in Israel.
Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
[TBL] [Abstract][Full Text] [Related]
7. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
8. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
[TBL] [Abstract][Full Text] [Related]
10. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
[TBL] [Abstract][Full Text] [Related]
11. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
12. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Christiaens GC; Hagenaars AM; Akkerman C; De France HF
Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
[TBL] [Abstract][Full Text] [Related]
13. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
Weiss BD
J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
15. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
16. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
[TBL] [Abstract][Full Text] [Related]
17. Elevated maternal serum alpha-fetoprotein values. How low is high?
Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
Candenas M; Villa R; Fernandez Collar R; Moina MJ; Pintado S; Garcia Saez F; Alvarez FV
Acta Obstet Gynecol Scand; 1995 Apr; 74(4):266-9. PubMed ID: 7537429
[TBL] [Abstract][Full Text] [Related]
19. First-trimester screening for neural tube defects using alpha-fetoprotein.
Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
[TBL] [Abstract][Full Text] [Related]
20. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?
Roman AS; Gupta S; Fox NS; Saltzman D; Klauser CK; Rebarber A
Fetal Diagn Ther; 2015; 37(3):206-10. PubMed ID: 25034077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
